Alerts

Health professionals and patients are advised that a review of post-market surveillance data has identified that the Adept 12/14 Modular Head has a higher than expected revision rate.

Health professionals and consumers are advised that sponsor, Sorin Group Australia, in consultation with the TGA, has issued a hazard alert for Isoline defibrillation leads.

Precautionary product notification for GlaxoSmithKline Australia (GSK) influenza vaccine, Fluarix

About seasonal flu vaccine: 2013 seasonal influenza vaccines for use in children

Updated information regarding patient follow-up for the ABGII Modular Femoral Stem and Modular Neck hip replacement system

Poly Implant Prothèse (PIP) update

The TGA has performed and reported on a large number of tests on the chemical properties, physical properties and the biological safety of the gels and shells of PIP breast implants.

PIP breast implants: Consumer questions & answers

GlaxoSmithKline (GSK) and Alphapharm, in consultation with the TGA, are undertaking a voluntary recall of several batches of Ventolin and Asmol inhalers due to a fault in the delivery mechanism of a small number of inhalers within each batch. This can lead to less than the full dose being delivered for each puff.

Poly Implant Prothèse (PIP) update

Health professionals and consumers are advised that Advanced Surgical Design & Manufacture (ASDM), in conjunction with the TGA, is investigating elevated failure rates of the patella (knee cap) component of the Active Knee System—an implant used in knee replacement procedures.

Poly Implant Prothèse (PIP) update

Poly Implant Prothèse (PIP) update